Home・Akcijų sąrašas・Compugen Ltd

Compugen Ltd

Uždarymo kaina

2.59 -2.63

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.59

Max

2.65

Pagrindiniai rodikliai
By Trading Economics
Pajamos	663K -7M
Pardavimai	426K 2.6M
P/E Sektoriaus vid.	6.351 57.371
Pelnas, tenkantis vienai akcijai	-0.07
Pelno marža	-269.254
Darbuotojai	75
EBITDA	665K -7M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+90.84% upside

Dividendai
By Acuity
Kitas uždarbis	2026-11-09

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-2.5M 223M
Ankstesnė atidarymo kaina	5.22
Ankstesnė uždarymo kaina	2.59

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-21 23:56; UTC

Mettler-Toledo shares are higher in after-market trading, reflecting a broader market rebound amid gains from major stocks like Tesla and UnitedHealth.

2026-08-21 23:56; UTC

Constellation Energy shares are higher in after-market hours, reflecting broader gains among major stocks. No specific news was identified for the price movement.

2026-08-21 23:56; UTC

Virtu Financial Inc. shares are higher in after-market trading, following a broader market rebound despite earlier pressures from rising crude oil prices and bond yields.

2026-08-21 23:56; UTC

TE Connectivity Ltd. shares declined in after-market trading, remaining near the lower end of their one-month range and below the 20-day moving average.

2026-08-21 23:56; UTC

APA Corp. is trading higher in after-market hours, reflecting broader market strength despite a recent yield-driven selloff. No specific news was identified.

2026-08-21 23:56; UTC

Social Media

Options trading for Costco includes a notable $950 call option that rose from $0.99 to $2.70. Shares remain roughly flat in after-market trading.

2026-08-21 23:56; UTC

MercadoLibre Inc. is higher in after-market hours, reflecting routine performance amid broader market gains following earlier pressure from rising crude oil prices and bond yields.

2026-08-21 23:56; UTC

NiSource shares are higher in after-market trading, reflecting broader market gains following a recent selloff. No specific company news was identified.

2026-08-21 23:56; UTC

OPKO Health Inc. shares declined in after-market trading, despite gains in major stocks as the broader market rebounded from earlier pressures.

2026-08-21 23:56; UTC

Agilent Technologies Inc shares are lower in after-market hours, diverging from broader market gains. No specific news was identified to explain the decline.

2026-08-21 23:56; UTC

Devon Energy Corp shows little change in after-market trading, remaining near unchanged since Friday's close and positioned 8.63% above its 20-day moving average.

2026-08-21 23:56; UTC

Ginkgo Bioworks Holdings Inc is higher in after-market trading amid a broader market rebound, despite no specific company news identified.

2026-08-21 23:56; UTC

Equitable Holdings Inc shares are lower in after-market hours, with no specific news identified. The stock remains below its 20-day moving average.

2026-08-21 23:56; UTC

Correlated Moves

US Bancorp shares are higher in after-hours trading, reflecting positive sentiment in the banking sector amid a broader market rebound.

2026-08-21 23:56; UTC

Intellia Therapeutics shares are higher in after-market trading, reflecting a broader market rebound following a recent yield-driven selloff.

2026-08-21 23:56; UTC

Macro News

ETF Constituents

Vanguard Information Technology ETF rises in after-market hours, supported by gains in key holdings like NVIDIA, Apple, and Intuit amid broader market recovery.

2026-08-21 23:56; UTC

Century Aluminum Co. shares gained after-market, recovering from an earlier dip. The movement reflects broader market trends amid rising crude oil prices and bond yields.

2026-08-21 23:56; UTC

Correlated Moves

Duke Energy shares rose in after-market trading, reflecting broader market gains despite remaining below the 20-day moving average after four consecutive lower sessions.

2026-08-21 23:56; UTC

B&G Foods Inc. traded roughly flat during after-market hours with no specific news. The broader market rebounded, but the stock remains near its one-month low.

2026-08-21 23:52; UTC

South Africa's Balance of Trade Report on August 28, 2026: Analysts Anticipate Continued Surplus Amid Global Economic Instability.

2026-08-21 23:52; UTC

S&P/Case-Shiller Home Price Index Release on August 25, 2026, Expected to Show Modest Growth Amid Mixed Housing Market Sentiment and Rising Inflation Concerns.

2026-08-21 23:52; UTC

US GDP Price Index QoQ 2nd Estimate for Q2, forecasted at a 0.063% increase, set to release on August 26 amid rising optimism in economic indicators and inflation concerns.

2026-08-21 23:52; UTC

XRP is trading higher during Friday's session, supported by a broader cryptocurrency rally and a U.S. Treasury announcement on bond buyback operations.

2026-08-21 23:51; UTC

Shares of Science Applications International Corp. are lower in after-market trading, reflecting a notable retracement despite being above the 20-day moving average.

2026-08-21 23:51; UTC

Karyopharm Therapeutics Inc shares are lower in after-market hours, following a brief uptick earlier. No specific news was identified to explain the decline.

2026-08-21 23:51; UTC

Par Pacific Holdings Inc. shares are lower in after-market hours, continuing a trend within the broader context of its one-month trading range.

2026-08-21 23:51; UTC

Paylocity Holding Corp shares are lower in after-market trading, with no specific news identified for the decline. The stock remains above its 20-day moving average.

2026-08-21 23:51; UTC

Shift4 Payments Inc is trading higher in after-market hours, supported by a rally in cryptocurrencies that benefits crypto-exposed equities.

2026-08-21 23:51; UTC

Coca-Cola Europacific Partners PLC shares are higher in after-market hours, recovering from an earlier dip amid broader market trends and a cryptocurrency rally.

2026-08-21 23:51; UTC

Kirby Corp shares are higher in after-market trading, reflecting a strong performance that exceeds the 20-day moving average. No specific news was identified.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

90.84% į viršų

12 mėnesių prognozė

Vidutinis 5 USD 90.84%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

Pirkti

Laikyti

Parduoti

Remiantis 2 analitikų, pateikusių Compugen Ltd akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.